Exhibit 23.2
| KPMG LLP |
| 345 Park Avenue |
| New York, NY 10154-0102 |
Consent of Independent Registered Public Accounting Firm
We consent to the use of our reports dated March 1, 2022, with respect to the consolidated financial statements of TG Therapeutics, Inc., and the effectiveness of internal control over financial reporting, incorporated herein by reference.
New York, New York
June 24, 2022